Stroke · 2009 · 133 citations · 10 references
MedicineNeurosciencePharmacologyClinical NeuroscienceNeuropharmacologyNeurophysiologyAcute Ischemic StrokeNeuroprotectionNeuroprotective PharmacologyStrokeStroke PharmacotherapyTraumatic Brain InjuryKetamine PharmacologyKetamine TherapyKetamine TreatmentN-methyl-d-aspartate Receptor AntagonismN-methyl-d-aspartate Receptor InhibitionNeuroprotective MechanismsNeuroprotective PharmacotherapyTraumatic Brain Injury Pharmacotherapy
BACKGROUND AND PURPOSE: Spreading depolarizations, characterized by large propagating, slow potential changes, have been demonstrated with electrocorticography in patients with cerebral hemorrhage and ischemic stroke. Whereas spreading depolarizations are harmless under normal conditions in animals, they cause or augment damage in the ischemic brain. A fraction of spreading depolarizations is abolished by N-methyl-d-aspartate receptor antagonists. Summary of Case- In 2 patients with severe acute brain injury (traumatic and spontaneous intracranial hemorrhage), spreading depolarizations were inhibited by the noncompetitive N-methyl-d-aspartate receptor antagonist ketamine. This restored electrocorticographic activity. CONCLUSIONS: These anecdotal electrocorticographic findings suggest that ketamine has an inhibitory effect on spreading depolarizations in humans. This is of potential interest for future neuroprotective trials.
10
Spreading and Synchronous Depressions of Cortical Activity in Acutely Injured Human Brain
Anthony J. Strong, Martin Fabricius, Martyn G. Boutelle et al. · Stroke · 2002 · 440 citations · Full text
Spreading depolarizations occur in human ischemic stroke with high incidence
Christian Dohmen, Oliver Sakowitz, Martin Fabricius et al. · Annals of Neurology · 2008 · 437 citations
Takehiko Iijima, G. Mies, Konstantin‐Alexander Hossmann · Journal of Cerebral Blood Flow & Metabolism · 1992 · 362 citations · Full text
Medicine, Neurobiology, Neuroscience +17